$XLRN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ACCELERON PHARMA INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in ACCELERON PHARMA INC. Get notifications about new insider transactions in ACCELERON PHARMA INC for free.

Page:   < prev 1 2 3 4 5 6 7 ... 11 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 29 2019XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...GrantA0.003,850093,99790.1 K to 94 K (+4.27 %)
Jan 29 2019XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...Option ExerciseA41.6425,5001,061,82025,500
Jan 29 2019XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...GrantA0.004,050010,0506 K to 10.1 K (+67.50 %)
Jan 29 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, CBO and Secret ...Option ExerciseA41.6428,5001,186,74028,500
Jan 29 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, CBO and Secret ...GrantA0.004,800057,45652.7 K to 57.5 K (+9.12 %)
Jan 29 2019XLRNACCELERON PHARMA I ...Zeldin Robert KEVP & Chief Medical ...Option ExerciseA41.6413,000541,32013,000
Jan 29 2019XLRNACCELERON PHARMA I ...Zeldin Robert KEVP & Chief Medical ...GrantA0.002,200019,10316.9 K to 19.1 K (+13.02 %)
Jan 29 2019XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...Option ExerciseA41.6428,0001,165,92028,000
Jan 29 2019XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...GrantA0.004,700042,92738.2 K to 42.9 K (+12.29 %)
Jan 29 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentOption ExerciseA41.64106,4004,430,496106,400
Jan 29 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentGrantA0.0017,700083,96866.3 K to 84 K (+26.71 %)
Jan 22 2019XLRNACCELERON PHARMA I ...CELGENE CORP /DE/BuyP43.00706,20630,366,8586,824,6856.1 M to 6.8 M (+11.54 %)
Jan 04 2019XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS43.9437416,43490,14790.5 K to 90.1 K (-0.41 %)
Jan 04 2019XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS43.203,051131,80390,52193.6 K to 90.5 K (-3.26 %)
Jan 04 2019XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS42.452,363100,30993,57295.9 K to 93.6 K (-2.46 %)
Jan 04 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, CBO and Secret ...SellS43.9247520,86252,65653.1 K to 52.7 K (-0.89 %)
Jan 04 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, CBO and Secret ...SellS43.102,558110,25053,13155.7 K to 53.1 K (-4.59 %)
Jan 04 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, CBO and Secret ...SellS42.311,30055,00355,68957 K to 55.7 K (-2.28 %)
Jan 04 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, CBO and Secret ...SellS43.2630012,97856,98957.3 K to 57 K (-0.52 %)
Jan 04 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, CBO and Secret ...SellS42.321,30955,39757,28958.6 K to 57.3 K (-2.23 %)
Jan 04 2019XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS44.06974,27438,22738.3 K to 38.2 K (-0.25 %)
Jan 04 2019XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS43.331,71774,39838,32440 K to 38.3 K (-4.29 %)
Jan 04 2019XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS42.562,18693,03640,04142.2 K to 40 K (-5.18 %)
Jan 04 2019XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS43.2030012,96042,22742.5 K to 42.2 K (-0.71 %)
Jan 04 2019XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS42.371,41259,82642,52743.9 K to 42.5 K (-3.21 %)
Jan 04 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS40.85271,10366,26866.3 K to 66.3 K (-0.04 %)
Jan 04 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS43.451,93083,85966,29568.2 K to 66.3 K (-2.83 %)
Dec 06 2018XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS54.3370038,03168,22568.9 K to 68.2 K (-1.02 %)
Dec 06 2018XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS53.655,607300,81668,92574.5 K to 68.9 K (-7.52 %)
Dec 06 2018XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS52.723,862203,60574,53278.4 K to 74.5 K (-4.93 %)
Dec 06 2018XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS51.542,506129,15978,39480.9 K to 78.4 K (-3.10 %)
Aug 31 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...Option ExerciseM27.9712,500349,62518,300
Aug 31 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS54.0012,500675,00043,93956.4 K to 43.9 K (-22.15 %)
Aug 31 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...BuyM27.9712,500349,62556,43943.9 K to 56.4 K (+28.45 %)
Jul 05 2018XLRNACCELERON PHARMA I ...Zeldin Robert KEVP & Chief Medical ...Option ExerciseA47.3385,5114,047,23685,511
Jul 05 2018XLRNACCELERON PHARMA I ...Zeldin Robert KEVP & Chief Medical ...GrantA0.0016,903016,9030 to 16.9 K
Jul 03 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...Option ExerciseM24.1125,000602,7504,000
Jul 03 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS49.0012,500612,50043,93956.4 K to 43.9 K (-22.15 %)
Jul 03 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS47.0012,500587,50056,43968.9 K to 56.4 K (-18.13 %)
Jul 03 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...BuyM24.1125,000602,75068,93943.9 K to 68.9 K (+56.90 %)
Apr 04 2018XLRNACCELERON PHARMA I ...Rovaldi ChristopherSVP, Program Mgmt a ...SellS39.0260023,41225,85826.5 K to 25.9 K (-2.27 %)
Apr 04 2018XLRNACCELERON PHARMA I ...Rovaldi ChristopherSVP, Program Mgmt a ...SellS38.272,900110,98326,45829.4 K to 26.5 K (-9.88 %)
Apr 04 2018XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS39.161003,91695,93596 K to 95.9 K (-0.10 %)
Apr 04 2018XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS38.341,10342,28996,03597.1 K to 96 K (-1.14 %)
Apr 04 2018XLRNACCELERON PHARMA I ...Quisel John DSVP, Corp. Dev., GC ...SellS39.161003,91656,59856.7 K to 56.6 K (-0.18 %)
Apr 04 2018XLRNACCELERON PHARMA I ...Quisel John DSVP, Corp. Dev., GC ...SellS38.331,10442,31656,69857.8 K to 56.7 K (-1.91 %)
Apr 04 2018XLRNACCELERON PHARMA I ...Sherman Matthew LEVP & Chief Medical ...SellS39.0490035,13668,76769.7 K to 68.8 K (-1.29 %)
Apr 04 2018XLRNACCELERON PHARMA I ...Sherman Matthew LEVP & Chief Medical ...SellS38.283,700141,63669,66773.4 K to 69.7 K (-5.04 %)
Apr 04 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS39.0080031,20043,93944.7 K to 43.9 K (-1.79 %)
Apr 04 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS38.313,200122,59244,73947.9 K to 44.7 K (-6.68 %)
Mar 23 2018XLRNACCELERON PHARMA I ...Maniatis TomDirectorOption ExerciseM5.0818,75095,2500
Mar 23 2018XLRNACCELERON PHARMA I ...Maniatis TomDirectorOption ExerciseM5.0818,75095,2500
Mar 23 2018XLRNACCELERON PHARMA I ...Maniatis TomDirectorBuyM5.0818,75095,250135,481116.7 K to 135.5 K (+16.06 %)
Mar 23 2018XLRNACCELERON PHARMA I ...Maniatis TomDirectorBuyM5.0818,75095,250135,481116.7 K to 135.5 K (+16.06 %)
Mar 08 2018XLRNACCELERON PHARMA I ...POPS RICHARD FDirectorOption ExerciseM5.0837,500190,5000
Mar 08 2018XLRNACCELERON PHARMA I ...POPS RICHARD FDirectorSellS42.322,902122,81331,25034.2 K to 31.3 K (-8.50 %)
Mar 08 2018XLRNACCELERON PHARMA I ...POPS RICHARD FDirectorSellS41.3434,5981,430,28134,15268.8 K to 34.2 K (-50.32 %)
Mar 08 2018XLRNACCELERON PHARMA I ...POPS RICHARD FDirectorBuyM5.0837,500190,50068,75031.3 K to 68.8 K (+120.00 %)
Mar 05 2018XLRNACCELERON PHARMA I ...Zakrzewski Joseph SDirectorOption ExerciseA40.617,500304,5757,500
Mar 05 2018XLRNACCELERON PHARMA I ...Zakrzewski Joseph SDirectorGrantA0.001,25006,5005.3 K to 6.5 K (+23.81 %)
Mar 05 2018XLRNACCELERON PHARMA I ...Smith Karen L.DirectorOption ExerciseA40.611,87576,1441,875
Mar 05 2018XLRNACCELERON PHARMA I ...Smith Karen L.DirectorGrantA0.0031203120 to 312
Mar 05 2018XLRNACCELERON PHARMA I ...POPS RICHARD FDirectorOption ExerciseA40.617,500304,5757,500
Mar 05 2018XLRNACCELERON PHARMA I ...POPS RICHARD FDirectorGrantA0.001,250031,25030 K to 31.3 K (+4.17 %)
Mar 05 2018XLRNACCELERON PHARMA I ...MCCOURT Thomas ADirectorOption ExerciseA40.617,500304,5757,500
Mar 05 2018XLRNACCELERON PHARMA I ...MCCOURT Thomas ADirectorGrantA0.001,25001,795545 to 1.8 K (+229.36 %)
Mar 05 2018XLRNACCELERON PHARMA I ...George JeanDirectorOption ExerciseA40.617,500304,5757,500
Mar 05 2018XLRNACCELERON PHARMA I ...George JeanDirectorGrantA0.001,25002,5001.3 K to 2.5 K (+100.00 %)
Mar 05 2018XLRNACCELERON PHARMA I ...Nader FrancoisDirectorOption ExerciseA40.617,500304,5757,500
Mar 05 2018XLRNACCELERON PHARMA I ...Nader FrancoisDirectorGrantA0.001,25002,5001.3 K to 2.5 K (+100.00 %)
Mar 05 2018XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...Option ExerciseA40.6126,7751,087,33326,775
Mar 05 2018XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...GrantA0.004,463097,13892.7 K to 97.1 K (+4.82 %)
Mar 05 2018XLRNACCELERON PHARMA I ...Rovaldi ChristopherSVP, Program Mgmt a ...Option ExerciseA40.6124,375989,86924,375
Mar 05 2018XLRNACCELERON PHARMA I ...Rovaldi ChristopherSVP, Program Mgmt a ...GrantA0.004,063028,76424.7 K to 28.8 K (+16.45 %)
Mar 05 2018XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...Option ExerciseA40.6150,0002,030,50050,000
Mar 05 2018XLRNACCELERON PHARMA I ...Quisel John DSVP, Corp. Dev., GC ...Option ExerciseA40.6128,9501,175,66028,950
Mar 05 2018XLRNACCELERON PHARMA I ...Quisel John DSVP, Corp. Dev., GC ...GrantA0.004,825057,80253 K to 57.8 K (+9.11 %)
Mar 05 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...Option ExerciseA40.6130,8251,251,80330,825
Mar 05 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...GrantA0.005,138047,93942.8 K to 47.9 K (+12.00 %)
Mar 05 2018XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentOption ExerciseA40.61108,8004,418,368108,800
Mar 05 2018XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentGrantA0.0018,100080,90062.8 K to 80.9 K (+28.82 %)
Feb 13 2018XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...GrantA0.006,00006,0000 to 6 K
Jan 17 2018XLRNACCELERON PHARMA I ...Rovaldi ChristopherSVP, Program Mgmt a ...Option ExerciseM24.1111,000265,21012,000
Jan 17 2018XLRNACCELERON PHARMA I ...Rovaldi ChristopherSVP, Program Mgmt a ...SellS45.0011,000495,00024,70135.7 K to 24.7 K (-30.81 %)
Jan 17 2018XLRNACCELERON PHARMA I ...Rovaldi ChristopherSVP, Program Mgmt a ...BuyM24.1111,000265,21035,70124.7 K to 35.7 K (+44.53 %)
Jan 04 2018XLRNACCELERON PHARMA I ...Rovaldi ChristopherSVP, Program Mgmt a ...SellS42.4583335,36124,70125.5 K to 24.7 K (-3.26 %)
Jan 04 2018XLRNACCELERON PHARMA I ...Rovaldi ChristopherSVP, Program Mgmt a ...SellS42.411,43360,77425,53427 K to 25.5 K (-5.31 %)
Jan 04 2018XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS42.414,300182,36392,67597 K to 92.7 K (-4.43 %)
Jan 04 2018XLRNACCELERON PHARMA I ...Quisel John DSVP, Corp. Dev., GC ...SellS42.424,333183,80652,97757.3 K to 53 K (-7.56 %)
Jan 04 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...Option ExerciseM5.286,25033,0000
Jan 04 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...Option ExerciseM3.886,25124,2540
Jan 04 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS43.842008,76842,80143 K to 42.8 K (-0.47 %)
Jan 04 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS43.0014,800636,40043,00157.8 K to 43 K (-25.61 %)
Jan 04 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...BuyM5.286,25033,00057,80151.6 K to 57.8 K (+12.12 %)
Jan 04 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...BuyM3.886,25124,25451,55145.3 K to 51.6 K (+13.80 %)
Jan 04 2018XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS42.424,000169,68045,30049.3 K to 45.3 K (-8.11 %)
Jan 04 2018XLRNACCELERON PHARMA I ...Sherman Matthew LEVP & Chief Medical ...SellS43.332,03388,09073,36775.4 K to 73.4 K (-2.70 %)
Jan 04 2018XLRNACCELERON PHARMA I ...Sherman Matthew LEVP & Chief Medical ...SellS42.402,30097,52075,40077.7 K to 75.4 K (-2.96 %)
Jan 04 2018XLRNACCELERON PHARMA I ...Sherman Matthew LEVP & Chief Medical ...SellS40.8630012,25877,70078 K to 77.7 K (-0.38 %)
Dec 18 2017XLRNACCELERON PHARMA I ...George JeanDirectorSellS35.73105,1223,756,0090105.1 K to 0 (-100.00 %)
Nov 15 2017XLRNACCELERON PHARMA I ...Smith Karen L.DirectorOption ExerciseA35.3420,000706,80020,000
Sep 29 2017XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...Option ExerciseM5.286,76135,6980
Sep 29 2017XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...BuyM5.286,76135,69896,97590.2 K to 97 K (+7.49 %)
Sep 25 2017XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyP37.00745,59227,586,9046,118,4795.4 M to 6.1 M (+13.88 %)
Sep 14 2017XLRNACCELERON PHARMA I ...Rovaldi ChristopherSVP, Program Mgmt a ...SellS39.961003,99626,96727.1 K to 27 K (-0.37 %)
Sep 14 2017XLRNACCELERON PHARMA I ...Rovaldi ChristopherSVP, Program Mgmt a ...SellS39.301,16545,78527,06728.2 K to 27.1 K (-4.13 %)
Sep 14 2017XLRNACCELERON PHARMA I ...Rovaldi ChristopherSVP, Program Mgmt a ...SellS38.3212,735488,00528,23241 K to 28.2 K (-31.09 %)
Sep 14 2017XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS38.12830590,21490.2 K to 90.2 K (-0.01 %)
Sep 14 2017XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS39.3950019,69590,22290.7 K to 90.2 K (-0.55 %)
Sep 14 2017XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS38.314,605176,41890,72295.3 K to 90.7 K (-4.83 %)
Sep 14 2017XLRNACCELERON PHARMA I ...Quisel John DSVP, Corp. Dev., GC ...SellS38.03830457,31057.3 K to 57.3 K (-0.01 %)
Sep 14 2017XLRNACCELERON PHARMA I ...Quisel John DSVP, Corp. Dev., GC ...SellS39.3760023,62257,31857.9 K to 57.3 K (-1.04 %)
Sep 14 2017XLRNACCELERON PHARMA I ...Quisel John DSVP, Corp. Dev., GC ...SellS38.294,505172,49657,91862.4 K to 57.9 K (-7.22 %)
Sep 14 2017XLRNACCELERON PHARMA I ...Sherman Matthew LEVP & Chief Medical ...SellS39.911505,98778,00078.2 K to 78 K (-0.19 %)
Sep 14 2017XLRNACCELERON PHARMA I ...Sherman Matthew LEVP & Chief Medical ...SellS39.241,60062,78478,15079.8 K to 78.2 K (-2.01 %)
Sep 14 2017XLRNACCELERON PHARMA I ...Sherman Matthew LEVP & Chief Medical ...SellS38.3216,650638,02879,75096.4 K to 79.8 K (-17.27 %)
Sep 14 2017XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS39.852108,36949,30049.5 K to 49.3 K (-0.42 %)
Sep 14 2017XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS39.171,30050,92149,51050.8 K to 49.5 K (-2.56 %)
Sep 14 2017XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS38.3214,490555,25750,81065.3 K to 50.8 K (-22.19 %)
Aug 09 2017XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...Option ExerciseM24.1113,065314,9973,624
Aug 09 2017XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS35.4113,065462,63295,327108.4 K to 95.3 K (-12.05 %)
Aug 09 2017XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...BuyM24.1113,065314,997108,39295.3 K to 108.4 K (+13.71 %)
Jul 07 2017XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...Option ExerciseM7.129376,6710
Jul 07 2017XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS32.0093729,98495,32796.3 K to 95.3 K (-0.97 %)
Jul 07 2017XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...BuyM7.129376,67196,26495.3 K to 96.3 K (+0.98 %)
Jul 07 2017XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...Option ExerciseM7.1218,750133,5000
Jul 07 2017XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...Option ExerciseM5.283,15016,6326,250
Jul 07 2017XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS32.0034,4001,100,80065,30099.7 K to 65.3 K (-34.50 %)
Jul 07 2017XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...BuyM7.1218,750133,50099,70081 K to 99.7 K (+23.16 %)
Jul 07 2017XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...BuyM5.283,15016,63280,95077.8 K to 81 K (+4.05 %)
Jul 07 2017XLRNACCELERON PHARMA I ...Sherman Matthew LEVP & Chief Medical ...Option ExerciseM7.128,00056,9600
Jul 07 2017XLRNACCELERON PHARMA I ...Sherman Matthew LEVP & Chief Medical ...SellS32.0016,000512,00096,400112.4 K to 96.4 K (-14.23 %)
Jul 07 2017XLRNACCELERON PHARMA I ...Sherman Matthew LEVP & Chief Medical ...BuyM7.128,00056,960112,400104.4 K to 112.4 K (+7.66 %)
Mar 14 2017XLRNACCELERON PHARMA I ...Zakrzewski Joseph SDirectorOption ExerciseA30.177,500226,2757,500
Mar 14 2017XLRNACCELERON PHARMA I ...Zakrzewski Joseph SDirectorGrantA0.001,25005,2504 K to 5.3 K (+31.25 %)
Mar 14 2017XLRNACCELERON PHARMA I ...POPS RICHARD FDirectorOption ExerciseA30.177,500226,2757,500
Mar 14 2017XLRNACCELERON PHARMA I ...POPS RICHARD FDirectorGrantA0.001,250030,00028.8 K to 30 K (+4.35 %)
Mar 14 2017XLRNACCELERON PHARMA I ...MCGUIRE TERRANCEDirectorOption ExerciseA30.177,500226,2757,500
Mar 14 2017XLRNACCELERON PHARMA I ...MCGUIRE TERRANCEDirectorGrantA0.001,25001,2500 to 1.3 K
Mar 14 2017XLRNACCELERON PHARMA I ...MCCOURT Thomas ADirectorOption ExerciseA30.173,27298,7163,272
Mar 14 2017XLRNACCELERON PHARMA I ...MCCOURT Thomas ADirectorGrantA0.0054505450 to 545
Mar 14 2017XLRNACCELERON PHARMA I ...Maniatis TomDirectorOption ExerciseA30.177,500226,2757,500
Mar 14 2017XLRNACCELERON PHARMA I ...Maniatis TomDirectorGrantA0.001,2500115,481114.2 K to 115.5 K (+1.09 %)
Mar 14 2017XLRNACCELERON PHARMA I ...Kearney Terrence CDirectorOption ExerciseA30.177,500226,2757,500
Mar 14 2017XLRNACCELERON PHARMA I ...Kearney Terrence CDirectorGrantA0.001,25001,2500 to 1.3 K
Mar 14 2017XLRNACCELERON PHARMA I ...George JeanDirectorOption ExerciseA30.177,500226,2757,500
Mar 14 2017XLRNACCELERON PHARMA I ...George JeanDirectorGrantA0.001,25001,2500 to 1.3 K
Mar 14 2017XLRNACCELERON PHARMA I ...Nader FrancoisDirectorOption ExerciseA30.177,500226,2757,500
Mar 14 2017XLRNACCELERON PHARMA I ...Nader FrancoisDirectorGrantA0.001,25001,2500 to 1.3 K
Mar 14 2017XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...Option ExerciseA30.1741,3001,246,02141,300

Page:   < prev 1 2 3 4 5 6 7 ... 11 next >